CD4+CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response

被引:64
作者
Fields, ML [1 ]
Hondowicz, BD [1 ]
Metzgar, MH [1 ]
Nish, SA [1 ]
Wharton, GN [1 ]
Picca, CC [1 ]
Caton, AJ [1 ]
Erikson, J [1 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
D O I
10.4049/jimmunol.175.7.4255
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the mechanism by which T regulatory (Treg) cells may control the early onset of autoimmunity, we have used an adoptive transfer model to track Treg, Th, and anti-chromatin B cell interactions in vivo. We show that anti-chromatin B cells secrete Abs by day 8 in vivo upon provision of undeviated, Th1- or Th2-type CD4(+) T cell help, but this secretion is blocked by the coinjection of CD4(+)CD25(+) Treg cells. Although Treg cells do not interfere with the initial follicular entry or activation of Th or B cells at day 3, ICOS levels on Th cells are decreased. Furthermore, Treg cells must be administered during the initial phases of the Ab response to exert full suppression of autoantibody production. These studies indicate that CD25(+) Treg cells act to inhibit the maturation, rather than the initiation, of autoantibody responses.
引用
收藏
页码:4255 / 4264
页数:10
相关论文
共 57 条
[21]  
Jordan MS, 2000, EUR J IMMUNOL, V30, P136, DOI 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.0.CO
[22]  
2-0
[23]   Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide [J].
Jordan, MS ;
Boesteanu, A ;
Reed, AJ ;
Petrone, AL ;
Holenbeck, AE ;
Lerman, MA ;
Naji, A ;
Caton, AJ .
NATURE IMMUNOLOGY, 2001, 2 (04) :301-306
[24]   THYMIC SELECTION OF CD8+ SINGLE POSITIVE CELLS WITH A CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED RECEPTOR [J].
KIRBERG, J ;
BARON, A ;
JAKOB, S ;
ROLINK, A ;
KARJALAINEN, K ;
VONBOEHMER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :25-34
[25]   GENETIC SUSCEPTIBILITY TO POST-THYMECTOMY AUTOIMMUNE-DISEASES IN MICE [J].
KOJIMA, A ;
PREHN, RT .
IMMUNOGENETICS, 1981, 14 (1-2) :15-27
[26]   Promotion of allograft survival by CD4+ CD25+ regulatory T cells:: Evidence for in vivo inhibition of effector cell proliferation [J].
Lee, K ;
Moore, DJ ;
Jarrett, BP ;
Lian, MM ;
Deng, SP ;
Huang, XL ;
Markmann, JW ;
Chiaccio, M ;
Barker, CF ;
Caton, AJ ;
Markmann, JF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :6539-6544
[27]   Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10 [J].
Löhning, M ;
Hutloff, A ;
Kallinich, T ;
Mages, HW ;
Bonhagen, K ;
Radbruch, A ;
Hamelmann, E ;
Kroczek, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :181-193
[28]   Extrafollicular antibody responses [J].
MacLennan, ICM ;
Toellner, KM ;
Cunningham, AF ;
Serre, K ;
Sze, DMY ;
Zúñiga, E ;
Cook, MC ;
Vinuesa, CG .
IMMUNOLOGICAL REVIEWS, 2003, 194 (01) :8-18
[29]   Regulatory T cells in the control of immune pathology [J].
Maloy, KJ ;
Powrie, F .
NATURE IMMUNOLOGY, 2001, 2 (09) :816-822
[30]   MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells [J].
Mandik-Nayak, L ;
Seo, SJ ;
Sokol, C ;
Potts, KM ;
Bui, A ;
Erikson, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1799-1814